Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
The White House has made it clear that Social Security and Medicare won't be affected by a proposed federal funding freeze. This freeze appeared to be off the table, after the initial OMB memo calling ...
To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...
The White House rescinded a pause on all Federal grants and loans, but the short-lived action shined a light on what could ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
Senator Rick Scott (R-FL) announced the reintroduction of his Protect Our Seniors Act, a legislative effort aimed at preserving and protecting Social Security ...
The Canadian Press on MSN1d
Fed hold rates steady, says job market is 'solid' while inflation 'remains somewhat elevated'The Federal Reserve left its benchmark interest rate unchanged Wednesday after cutting it three times in a row last year, a ...
The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation ...
The Chicago-based association will also "pick and choose" its advocacy fights regarding topics like vaccines, gender ...
The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback